Kessler is an elite rim protector with a limited offensive repertoire and a spotty health record. L.A. needs him to maximize ...

Korn Ferry's Executive Search and Professional Search & Interim segments delivered higher pricing and margin expansion. Find ...

With lower running costs, better technology, and energy security concerns persuading Indians to make EVs their first choice, ...

Tencent Cloud used over 20 agentic AI skills to migrate Indonesian telecom XLSMART's core systems in 4.5 months with zero ...

Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.

India’s hospital rally may be entering a new phase. While FIIs crowded into Apollo and Max Healthcare, a few mid-sized players are showing faster operational growth, improved occupancy, and strong ...

Let's Try was able to grow its revenue 212% from ₹65 Cr in FY25 to around ₹203 Cr in FY26. The startup is yet to file its ...

With the Warriors set to keep the 11th pick, there are a ton of prospects like Nate Ament and Yaxel Lendeborg that can improve their roster.

Discover how regional carriers like Viaero are attracting rural wireless customers through localized service, expanded ...

The Polish border with Belarus is peaceful on this warm afternoon, the silence broken only by our guides as we walk along one ...

Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease ...

Scientists at ETH Zurich have identified a compound that sharply reduced nerve-cell death in mice engineered to develop ...